MAURISHA TAYLOR: Open Payments
NPI 1205507522 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 12 payments from 7 companies in 2025. Trend: 2023 $26 · 2024 $342 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $94 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Resmed Corp | 1 | $15 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, VOQUEZNA, AIRSENSE.
Industry payments across GA — which companies pay providers there.
